- トップ
- 研究業績
- Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y. Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematol Onco 36(1):202-209, Feb, 2018 (doi: 10.1002/hon.2452.) Epub Jul 6, 2017
Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y. Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematol Onco 36(1):202-209, Feb, 2018 (doi: 10.1002/hon.2452.) Epub Jul 6, 2017
2023/08/05
- 研究業績
- Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y. Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematol Onco 36(1):202-209, Feb, 2018 (doi: 10.1002/hon.2452.) Epub Jul 6, 2017
« 坂田（柳元）麻実子：血管免疫芽球性T細胞リンパ腫（angioimmunoblasitc T-cell lymphoma:... | Nakajima T, Enomoto Y, Ishigaki M, Hasegawa Y, Tokunaga C, Hiramats... »
